India’s corporate landscape witnessed a flurry of strategic moves in May 2025, as companies across sectors such as pharmaceuticals, energy, engineering, and real estate announced acquisitions, investments, and global expansions. From Hindalco’s large-scale industrial alignment to Aurobindo’s overseas biosimilar footprint, each move highlights a broader intent to capture future-ready growth opportunities. Here’s a curated roundup of the most significant deals that signal the direction India Inc. is heading.
1. Hindalco Industries – EMIL Acquisition Proposal
Deal Value: Rs 4,200 Cr
Status: Approval in process
Sector: Metals & Mining
Insight: Hindalco seeks to acquire EMIL to enhance its access to key resources and integrate operations across the aluminum value chain. This aligns with its strategic focus on backward integration and cost optimization in a volatile commodity environment.
2. Aurobindo Pharma – Expansion into Europe
Entity Formed: CuraTeQ Biologics B.V., Netherlands
Date: May 28, 2025
Sector: Biologics / Pharma
Insight: This new entity gives Aurobindo a direct foothold in the regulated EU market, aiming to accelerate its biosimilars portfolio development and leverage cross-border R&D talent.
3. Kothari Products – Stake in Sai Veeran Agencies
Stake Acquired: 80%
Value: Rs 118.32 Cr
Sector: Real Estate
Insight: Traditionally known for its trading businesses, Kothari Products has deepened its presence in the real estate segment through this strategic acquisition, possibly targeting income-generating properties or development rights.
4. Maithan Alloys – Stake Purchase in GAIL (India) Ltd.
Shares Acquired: 6.19 lakh
Value: Rs 12.03 Cr
Stake: 0.009%
Date: May 27, 2025
Insight: Though a small stake, this move shows Maithan Alloys’ interest in diversifying into stable, dividend-paying PSU stocks with strong balance sheets.
5. Zydus Lifesciences – Renewable Energy Investment
Entities: Torrent Urja 25 (22.06%) & 26 (26.20%)
Sector: Lifesciences / Renewables
Insight: Zydus is moving towards green energy, ensuring ESG compliance and reducing energy dependency, a trend increasingly seen among large pharma players.
6. Fortis Healthcare – Shrimann Hospital Acquisition
Status: Finalized after legal injunction lifted
Date: May 13, 2025
Sector: Healthcare
Insight: This acquisition strengthens Fortis’s presence in North India. With the regulatory hurdles cleared, it paves the way for integration and expansion of healthcare services.
7. RHI Magnesita – Investment in Intermetal Engineers
Shares: 150
Per Share Price: Rs 1,66,475
Total Investment: 2.5 Cr
Sector: Engineering
Insight: This small but strategic investment could provide RHI access to niche engineering IP, talent, or manufacturing solutions.
8. Enviro Infra Engineers – Full Acquisition of Sunaxis Renewables
Stake Acquired: 100%
Value: Rs1,00,000
Sector: Renewables
Insight: With this move, Enviro Infra adds a wholly owned subsidiary focused on green energy, likely to support government-aligned sustainability mandates.
9. Chatha Foods – Fundraising via Equity Allocation
Equity Issued: 69.3 lakh shares
Value: Rs6.93 Cr
Investor: Allana CF Foods Pvt Ltd
Sector: Food & FMCG
Insight: The capital infusion could support Chatha’s manufacturing, distribution, or export capabilities, as demand for frozen and ready-to-eat segments grows.
About Indira Securities:
Indira Securities is a leading financial services firm offering research-backed equity advisory, portfolio management, and wealth solutions. With a strong presence in India’s capital markets for over two decades, Indira aims to empower investors with timely insights and smart strategies for wealth creation.
Written by Indira Securities SEBI Registered with 30 plus years of experience in Stock Market!!!